Neoleukin Therapeutics
Stock Forecast, Prediction & Price Target
Neoleukin Therapeutics Financial Estimates
Neoleukin Therapeutics Revenue Estimates
Neoleukin Therapeutics EBITDA Estimates
Neoleukin Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $451K N/A | $6K -98.66% | $0 -100% | Avg: $0 Low: $0 High: $0 avg. 0% | |||
Net Income
% change YoY
| $-24.95M N/A | $-58.41M -134.07% | $-56.01M 4.10% | Avg: $-200.17M Low: $-200.17M High: $-200.17M avg. -257.34% | |||
EBITDA
% change YoY
| $-47.56M N/A | $-60.69M -27.61% | $-56.48M 6.94% | Avg: $0 Low: $0 High: $0 avg. 100% | |||
EPS
% change YoY
| -$0.48 N/A | -$1.06 -120.83% | -$1.01 4.71% | Avg: -$3.63 Low: -$3.63 High: -$3.63 avg. -258.91% | |||
Operating Expenses
% change YoY
| $41.55M N/A | $60.69M 46.07% | $59.09M -2.63% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Neoleukin Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -257.34% in 2025-2025.
We have gathered data from N/A analysts. Their low estimate is -200.17M, average is -200.17M and high is -200.17M.
What is Neoleukin Therapeutics stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Neoleukin Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -258.91% in 2025-2025.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$3.63, average is -$3.63 and high is $-3.62.